What it is
Sigumir is a peptide supplement designed to support joint and musculoskeletal health. It functions as a cartilage peptide bioregulator, available in capsule form for adult use.
Supplement · Peptide
Sigumir
20 mg · vegan · gluten-free · 30 caps
joint stiffnessjoint painmuscle-weakness jointbonemuscle
Affiliate link · we earn from qualifying purchases. No paid placements.
How it works
Sigumir acts on joint, muscle, and bone tissues, with effects becoming measurable within 4-12 weeks for joint comfort. Consistency is key for efficacy in this peptide class.
Who should take it
Adults looking to address joint stiffness, muscle weakness, joint pain. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
Avoid / careful
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
When to take it
Morning
Noon
Evening
Night
How to take it
With food
Empty stomach
Before food
FAQs
Frequently asked
How long does it take to see results from Sigumir?
For joint comfort, effects are typically measurable within 4 to 12 weeks of consistent use.
Can Sigumir be taken with other supplements?
Yes, Sigumir can be layered into a broader protocol, but consult a clinician if you are on prescription medication affecting similar pathways.
What are the potential side effects of Sigumir?
Side effects are uncommon at recommended doses, but mild gastrointestinal upset may occur when starting the supplement.
Research
6 studies · 2010–2024
Evidence grade
ABCD
C · C · emerging-to-moderate human evidence for joint and musculoskeletal health
From the blog
Editorial notes
SacredBod's longer take on Sigumir — context the structured blocks above don't capture.
About Sigumir
Sigumir is a peptide supplement used to support joint and musculoskeletal health. Cartilage peptide bioregulator (research). It is available in capsule form and dosed for adults in India and internationally. As a peptide-tradition entry in the SacredBod catalog, it is positioned as a single-ingredient option that can be used on its own or layered into a broader protocol. Sigumir works through the mechanisms characteristic of its class — see the mechanism and research sections for detail. It primarily acts on the joints, muscles, bones, and effects are dose-dependent, typically becoming measurable within 4-12 weeks for joint comfort. Consistency matters more than dose size for this category.
Evidence
Sigumir carries an evidence grade of C in the SacredBod catalog, reflecting emerging human evidence for joint and musculoskeletal health. Cartilage peptide bioregulator (research). Benefits are cumulative rather than immediate, typically becoming noticeable within 4-12 weeks for joint comfort, and individual response varies.
Dosing
A typical dose is 20 mg, taken with food, usually in the morning. Start at the lower end, assess tolerance, and stay consistent; more is not automatically better.
Cautions
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
Who it’s for
Adults looking to address joint stiffness, muscle weakness, joint pain. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
As part of the Peptide category, Sigumir can be used on its own or layered into a broader protocol — see the Goes with panel for evidence-aligned pairings.
Added to your stack.